A La Jolla immunologist at the Salk Institute has helped chart some of the tiniest peace offerings your food can make to your immune system: short protein fragments in corn, wheat and soy that quietly tell the gut, this is safe. The work, published this month, points to antigen-focused strategies that researchers hope could eventually help prevent or dial down food allergies.
The peer-reviewed study, released March 6 in Science Immunology, used high-throughput T-cell receptor mapping and expression cloning to zero in on three short epitopes, one each from corn, wheat and soybean. These fragments bind regulatory T cells and appear to drive oral tolerance. The authors report that these seed-storage protein pieces, including an α-zein peptide from maize, recruit intestinal Tregs that blunt immune reactions in mice.
How Researchers Tracked the Signals
The team started with something decidedly un-fancy: ordinary mouse chow. From there, they isolated intestinal regulatory T cells, sequenced their receptors and used a cDNA-screening approach to hunt down the matching antigens. That workflow, and its single-cell methods, are laid out in coverage from Stanford Report, which explains how the group “de-orphaned” TCRs to reveal the specific food-derived epitopes behind the tolerant response.
A Local Scientist's Role
Jamie Blum, who ran the experiments at Stanford and recently moved to La Jolla to launch the Blum Lab at the Salk Institute, is the paper's first and co-corresponding author. "Understanding how the immune system can normally see a protein as safe may lead to new therapies," she said in a statement from the Salk Institute.
Potential and Limits
By putting specific molecular addresses on oral tolerance, the discovery gives immunologists a concrete handle on how the gut learns to live with everyday foods. It also raises the possibility of designing tolerance-favoring peptides as highly targeted immunotherapies rather than relying only on broad desensitization approaches.
At the same time, observers are quick to stress that all of this is still rooted in mouse models. Turning these findings into human treatments will require mapping equivalent human epitopes and then running extensive validation studies, according to coverage by MedicalXpress. In other words, not exactly something your allergist can prescribe next week.
Reagents and Next Steps
The paper notes that the researchers used MHC tetramers to track antigen-specific T cells and that these specialized reagents are supplied through the NIH Tetramer Core Facility. The study's methods and materials are documented on the paper's PubMed page for other labs to consult. By making reagents and code available, the team aims to let other groups test whether similar tolerance-driving peptides can be identified in humans.
What It Means for La Jolla
Blum formally joined Salk's NOMIS Center for Immunobiology and Microbial Pathogenesis in September 2025 and is now recruiting postdocs to keep hunting for dietary antigens at the Blum Lab. Local coverage of her hire and the new paper appeared in The San Diego Union-Tribune, underscoring La Jolla's increasingly central role in allergy and immunology research.
Food allergies remain a significant public-health concern, and estimates from Food Allergy Research & Education put clinician-diagnosed pediatric food allergy at roughly 5–6% of children. Researchers say that mechanistic leads like these therefore deserve careful follow-up. For now, the study offers a solid molecular starting point, while patients and clinicians should expect a long road before any tolerance-based therapies reach the clinic.
